These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23942223)

  • 1. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies.
    Golabek T; Bukowczan J; Chłosta P; Powroźnik J; Dobruch J; Borówka A
    Urol Int; 2014; 92(1):7-14. PubMed ID: 23942223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and renal cancer incidence and mortality--a systematic review of prospective cohort studies.
    Golabek T; Bukowczan J; Szopinski T; Chlosta P; Lipczynski W; Dobruch J; Borowka A
    Ann Agric Environ Med; 2016; 23(1):37-43. PubMed ID: 27007516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.
    Rundle A; Wang Y; Sadasivan S; Chitale DA; Gupta NS; Tang D; Rybicki BA
    Prostate; 2017 Jun; 77(9):949-954. PubMed ID: 28349547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and prostate cancer: epidemiology and clinical implications.
    Buschemeyer WC; Freedland SJ
    Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of obesity on overall and cancer specific survival in men with prostate cancer.
    Davies BJ; Smaldone MC; Sadetsky N; Dall'era M; Carroll PR
    J Urol; 2009 Jul; 182(1):112-7; discussion 117. PubMed ID: 19447437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and prostate cancer: making sense out of apparently conflicting data.
    Freedland SJ; Platz EA
    Epidemiol Rev; 2007; 29():88-97. PubMed ID: 17478439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.
    Discacciati A; Orsini N; Wolk A
    Ann Oncol; 2012 Jul; 23(7):1665-71. PubMed ID: 22228452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer.
    Nassar ZD; Aref AT; Miladinovic D; Mah CY; Raj GV; Hoy AJ; Butler LM
    BJU Int; 2018 May; 121 Suppl 3():9-21. PubMed ID: 29460324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies.
    Geczik AM; Kelly SP; Pfeiffer RM; Huang WY; Liao LM; Zhou CK; Brinton LA; Cook MB
    Cancer Med; 2021 Jan; 10(1):405-415. PubMed ID: 33219755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
    Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study.
    Discacciati A; Orsini N; Andersson SO; Andrén O; Johansson JE; Wolk A
    Br J Cancer; 2011 Sep; 105(7):1061-8. PubMed ID: 21847119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Alcohol Intake and Prostate Cancer Mortality and Survival.
    D'Ecclesiis O; Pastore E; Gandini S; Caini S; Marvaso G; Jereczek-Fossa BA; Corrao G; Raimondi S; Bellerba F; Ciceri S; Latella M; Cavalcabò NB; Bendinelli B; Saieva C; Fontana M; Gnagnarella P
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and prostate cancer: an insight into postmodern medicine.
    Siddiqui SA
    J Urol; 2009 Jul; 182(1):14-5. PubMed ID: 19450848
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
    Orsted DD; Nordestgaard BG; Jensen GB; Schnohr P; Bojesen SE
    Eur Urol; 2012 May; 61(5):865-74. PubMed ID: 22104593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
    Astorg P
    Cancer Causes Control; 2004 May; 15(4):367-86. PubMed ID: 15141138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.
    Cai H; Xu Z; Xu T; Yu B; Zou Q
    Diabetes Metab Res Rev; 2015 May; 31(4):336-43. PubMed ID: 25066306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study.
    Klemann N; Røder MA; Helgstrand JT; Brasso K; Toft BG; Vainer B; Iversen P
    Lancet Oncol; 2017 Feb; 18(2):221-229. PubMed ID: 28094199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
    Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
    Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between nutrition and prostate cancer: is more always better?
    Masko EM; Allott EH; Freedland SJ
    Eur Urol; 2013 May; 63(5):810-20. PubMed ID: 23219353
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.